Docetaxel-induced pericardial effusion

Dogan S. E., Mizrak D., Alkan A., DEMİRKAZIK A.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.23, no.5, pp.389-391, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 5
  • Publication Date: 2017
  • Doi Number: 10.1177/1078155216643859
  • Journal Name: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.389-391
  • Keywords: Docetaxel, pericardial effusion, side effect, INTRAVENOUS-INFUSION, CANCER-PATIENTS, BREAST-CANCER, PHASE-II, TRIAL
  • Lokman Hekim University Affiliated: No

Abstract

Hypersensitivity reactions, cumulative fluid retention, and neurotoxicity are frequently seen toxicities related to docetaxel. Fluid retention may be present as edema, weight gain, or third place fluid collection. Pericardial effusion is rarely seen with docetaxel treatment. We report a 58-year-old female patient who was presented with pericardial tamponade after three cycles of docetaxel therapy.